National Center for Advancing Translational Sciences; Notice of Closed Meetings, 5635 [2018-02492]

Download as PDF 5635 Federal Register / Vol. 83, No. 27 / Thursday, February 8, 2018 / Notices include homeless assistance purposes as a permissible use under public health. The Federal Asset and Transfer Act of 2016 (Pub. L. 114–287) streamlined the Title V process bifurcating the application process. Transfers are made to transferees at little or no cost. determine if institutions/organizations are eligible to purchase, lease or use property under the provisions of the surplus real property program. Responds are intermittent—only when an eligible organization requests acquisition of identified Federal surplus real property. We are requesting that the collection be valid for three years. Type of respondent: State and local governments and non-profit institutions use these applications to apply for excess/surplus, underutilized/ unutilized and off-site government real property. These applications are used to ESTIMATED ANNUALIZED BURDEN TABLE Number of respondents Type of respondent Number responses per respondent Average burden per response (in hours) Total burden hours Applications for surplus Federal real property ................................................. 15 1 200 3,000 Total .......................................................................................................... 15 1 200 3,000 Terry S. Clark, Office of the Secretary, Asst. Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2018–02477 Filed 2–7–18; 8:45 am] BILLING CODE 4150–04–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meetings daltland on DSKBBV9HB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; R13 Conference Grants Review. Date: March 6, 2018. Time: 1:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, Room 1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, 6701 Democracy Blvd., Rm. 1078, Bethesda, MD 20892, 301– 594–7319, khanr2@csr.nih.gov. VerDate Sep<11>2014 17:18 Feb 07, 2018 Jkt 244001 Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; TRND—Contract Review. Date: March 7, 2018. Time: 1:00 p.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, One Democracy Plaza, Room 1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, 6701 Democracy Blvd., Rm. 1078, Bethesda, MD 20892, 301– 894–7319, khanr2@csr.nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Platform Delivery Technologies for Nucleic Acid Therapeutics. Date: March 29, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, Room 1065, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Carol Lambert, Ph.D., Acting Director, Office of Scientific Review, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 6701 Democracy Blvd., Democracy 1, Room 1076, Bethesda, MD 20892, 301–435– 0814, lambert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: February 1, 2018. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–02492 Filed 2–7–18; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Pain Mechanisms. Date: March 1, 2018. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John Bishop, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Integrative Neuroscience. Date: March 1, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 83, Number 27 (Thursday, February 8, 2018)]
[Notices]
[Page 5635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02492]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; R13 Conference Grants Review.
    Date: March 6, 2018.
    Time: 1:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm. 1078, Bethesda, MD 
20892, 301-594-7319, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; TRND--Contract Review.
    Date: March 7, 2018.
    Time: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1037, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm. 1078, Bethesda, MD 
20892, 301-894-7319, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; Platform Delivery Technologies for 
Nucleic Acid Therapeutics.
    Date: March 29, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, Room 
1065, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Carol Lambert, Ph.D., Acting Director, Office of 
Scientific Review, National Center for Advancing Translational 
Sciences (NCATS), National Institutes of Health, 6701 Democracy 
Blvd., Democracy 1, Room 1076, Bethesda, MD 20892, 301-435-0814, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: February 1, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02492 Filed 2-7-18; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.